Vincent Rajkumar’s 2024 update on diagnosis, risk stratification, and treatment of myeloma

Vincent Rajkumar shared on X:

“Just out:

My 2024 Update on diagnosis, risk stratification, and treatment of myeloma.

10 Tables; Algorithms Includes current data including trials published this month!

Major changes:

Algorithm for newly diagnosed myeloma has changed.

Quadruplets recommended for all patients as initial therapy except those who are frail.

Major Update:

Incorporation of bispecifics and CART for relapsed myeloma treatment.

Results of recent phase III trials with immunotherapy in myeloma.

Check it out here.”

Source: Vincent Rajkumar/X

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.

His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.